Cycn investor relations
WebCYCN Earnings Date Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings Forecast Change in Consensus … WebSummary Financials Analysis Earnings Investors. . . Key Ratios Income Statement Balance Sheet Cash Flow. All. Per Share Values. Growth Rates. ... CYCN 2024. CYCN 3-Yr Avg. Biotech. 1-Yr Avg. Asset ...
Cycn investor relations
Did you know?
WebJan 12, 2024 · Review Cyclerion Therapeutics Inc Ordinary Shares (CYCN:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions. WebMar 2, 2024 · Investor Relations Cyclerion Therapeutics Inc Ordinary Shares CYCN Executive Morningstar Rating Rating as of Mar 2, 2024 Quote Chart Stock Analysis News Price vs Fair Value ...
WebCAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that the Board of Directors of the Company acting … WebCyclerion Therapeutics - CYCN - Stock Price Today - Zacks Cyclerion Therapeutics (CYCN) (Real Time Quote from BATS) $0.64 USD -0.01 (-1.55%) Updated Mar 7, 2024 03:58 PM ET Add to portfolio...
WebOct 30, 2024 · Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announces positive dude iligence 01/09/20 3:36 PM CYCN $3.05 chart huge potential How Big HUGE! Actualfactual 01/08/20 2:21 PM Broke... WebHere are some key insights as we drill into the specifics of these quality attributes. CYCN has a Quality Grade of C, ranking ahead of 48.21% of graded US stocks. CYCN's asset turnover comes in at 0.034 -- ranking 346th of 682 Pharmaceutical Products stocks. The table below shows CYCN's key quality metrics over time.
WebInstitutional investors control 48.45% of the outstanding shares in CYCN. This represents a greater percentage of ownership than at almost any other company in the …
WebAug 10, 2024 · Cyclerion Therapeutics, Inc. Common Stock (CYCN) Nasdaq Listed 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Pre-Market Charts … city flight ltdWebNov 22, 2024 · The Investor Relations website contains information about Cyclerion Therapeutics, Inc.'s business for stockholders, potential investors, and financial … CNS is a high-reward space with large and growing unmet need due to an aging … Leveraging a Critical Pathway. Cyclerion was founded with the goal of unlocking … Culture & Careers. We have an exceptional team at Cyclerion with a vibrant and … Investor Resources; Culture & Careers; Our Commitment. We are committed to … dicyclomine and gas xWebApr 11, 2024 · Cyclerion Therapeutics stock was originally listed at a price of $12.50 in Mar 18, 2024. If you had invested in Cyclerion Therapeutics stock at $12.50, your return over the last 4 years would have been -95.68%, for an annualized return of -54.41% (not including any dividends or dividend reinvestments). city flight luxeWebSummary Financials Analysis Earnings Investors. . . Key Ratios Income Statement Balance Sheet Cash Flow. All. Per Share Values. Growth Rates. ... CYCN 2024. CYCN 3-Yr Avg. … dicyclomine and famotidine togetherWebApr 6, 2024 · Of the 23 institutional investors that sold Cyclerion Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vanguard Group Inc. ($0.47M), State Street Corp ($0.32M), Renaissance Technologies LLC ($0.32M), Northern Trust Corp ($0.19M), FMR LLC ($0.13M), New … dicyclomine and gerdWebCYCN Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 55 Institutional Holders 21,001,047 Total Shares Held Back to CYCN Overview … cityflo bus bookingWebMar 15, 2024 · Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, … cityflo 350